×
Stockreport

Seattle Genetics Dives To Low After Leukemia Drug Tied To Deaths [Investor's Business Daily]

SEATTLE GENETICS (SGEN)  More Company Research Source: Investors Business Daily

IMPACT SNAPSHOT EVENT TIME: SGEN
Last Price
Price Change
Price Change %
Volume
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME
TICKS

AVG TRANSACTION SIZE

+ 0.14%

SGEN's stock exhibits minor increase of +0.14% from 61.65-share to 61.74-share since news was released

0.00177289146757465 0.00201619770740649 0.00112407482802313 0.00599019962465962 0.00258391226701403 0.00712562874387481 0.0202641656947935 0.0131271826597265
EVENT DAY
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Stockreport

IMPACT SNAPSHOT
EVENT TIME:
SGEN
Last Price
Price Change
Price Change %
Volume
Max Up
Max Down
Volume Ratio
%
+ 0.14%

SGEN's stock exhibits minor increase of +0.14% from 61.65-share to 61.74-share since news was released

Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME
TICKS

AVG TRANSACTION SIZE

EVENT DAY
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS